Emapalumab as a therapeutic intervention for Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis: A case series
The findings suggest that emapalumab may be an effective and safe treatment option for pediatric EBV-HLH. However, further research is necessary to confirm these outcomes, especially in critically ill patients.
Authors
- Fuyu Pei (ORCID: https://orcid.org/0009-0008-8409-9189)
- Yuan Xiao (ORCID: https://orcid.org/0000-0002-2878-3217)
- Li Yu
- Wen Wang (ORCID: https://orcid.org/0000-0002-2350-3562)
Institutions
- Nanfang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1097/md.0000000000039880
- Citations
- 7
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 3.18